We are Prescient. We turn science into value for the biopharma industry.
The science of a molecule is rarely what determines whether a drug will become the market leader; people determine whether the molecule becomes that market leader—by translating the scientific potential into a value proposition that resonates with stakeholders making it relevant, differentiated, meaningful.
We help biopharmaceutical clients develop winning strategies for their molecules every single day. Giving the molecules in your hands a greater potential for success than the same science in the hands of your competitors.
We travel the drug development and commercialization journey
No matter where you are on the drug development and commercialization journey, Prescient in there. From early development to launch, from the critical first 12 months on the market to loss of exclusivity, we’re by your side, providing the dynamic insight, expertise, objectivity and creativity required to make aligned decisions, differentiated decisions, valuable decisions.
At Prescient, science is at the core of everything we do. We are experts at maximizing the value of science for your patients, your company and you.
By understanding the potential of your molecules, we can frame your options and make decision making the biggest differentiating factor in your products’ success. We take a forward-looking approach, anticipating the future and helping you prepare for what’s ahead.
By: Ben Doran, Stuart Crichton, Ben Druck and Vasiliki Patsioura. The Prescient team has prepared a white paper discussing our view on the recent advances in the CAR-T landscape. In this paper, we do [...]
Our client was a global biopharmaceutical company with a market-leading brand more than 20 years’ old. It came under intense pricing pressure due to generic entries from companies known to play primarily on price. The company faced issues in identifying key investment areas to help maintain the brand’s market leader position. Prescient was engaged to reevaluate the client’s business model through a series of projects designed to help the client
Our global pharmaceutical client had a product whose patent was expiring within a year. The client wanted to understand the potential impact of generic competition on its brand in key revenue markets. Prescient was engaged to develop tactics to defend market share in these markets by:
Our client, a European specialty pharmaceutical company, was considering an expansion of indications within its target therapeutic group via licensing and acquiring products that were in clinical development, soon-to-be-launched or already marketed. The client engaged Prescient to prepare a comprehensive commercial valuation of a late-stage licensing opportunity to support the assessment of a go/no-go decision and subsequent submission of a non-binding offer, resulting in full due diligence or potential negotiation and closing of a deal or partnership.
Turn your expertise into a valuable career at Prescient
We are looking for people who want to immerse themselves in a passionate community of experts focused on bringing innovative, life-enhancing drugs to patients.
Whether you’ve just graduated from university, a scientist looking for a change, a seasoned consultant wanting to specialize or an industry professional with an entrepreneurial spirit, at Prescient, you have the opportunity to excel and do work that matters.
Prescient is an exciting and fast-growing private equity-backed biopharma strategy firm. But we are so much more than that—because the work we do is so much bigger than that.